Entity Common Stock, Shares Outstanding of Summit Therapeutics Inc. from 31 Jan 2018 to 17 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Summit Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jan 2018 to 17 Feb 2026.
  • Summit Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending 17 Feb 2026 was 775,372,700, a 4.4% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Summit Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 775,372,700 +32,706,776 +4.4% 17 Feb 2026 10-K 23 Feb 2026 2025 FY
Q3 2025 744,442,538 +6,994,392 +0.95% 14 Oct 2025 10-Q 20 Oct 2025 2025 Q3
Q2 2025 742,846,672 +18,308,921 +2.5% 05 Aug 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 742,665,924 +40,686,328 +5.8% 25 Apr 2025 10-Q 01 May 2025 2025 Q1
Q3 2024 737,448,146 +36,605,248 +5.2% 23 Oct 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 724,537,751 +26,852,386 +3.8% 30 Jul 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 701,979,596 +4,294,231 +0.62% 22 Apr 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 701,697,179 09 Feb 2024 10-K 20 Feb 2024 2023 FY
Q3 2023 700,842,898 +499,521,723 +248% 31 Oct 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 697,685,365 +599,563,009 +611% 02 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 697,685,365 +599,563,009 +611% 07 Mar 2023 10-K 09 Mar 2023 2022 FY
Q3 2022 201,321,175 +103,606,728 +106% 02 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 98,122,356 +740,582 +0.76% 04 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 98,122,356 +15,206,167 +18% 10 Mar 2022 10-K/A 21 Dec 2022 2021 FY
Q3 2021 97,714,447 +15,454,443 +19% 08 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 97,381,774 05 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 82,916,189 24 Mar 2021 10-K 31 Mar 2021 2020 FY
Q3 2020 82,260,004 11 Nov 2020 10-Q 16 Nov 2020 2020 Q3
Q4 2019 335,890,281 +175,500,400 +109% 31 Dec 2019 20-F 30 Apr 2020 2019 FY
Q4 2018 160,389,881 +86,826,257 +118% 31 Jan 2019 20-F 29 Mar 2019 2019 FY
Q2 2018 0 05 Jun 2018 6-K 05 Jun 2018 2019 FY
Q4 2017 73,563,624 31 Jan 2018 20-F 13 Apr 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.